Epigral Limited
NSE: EPIGRALINE071N01016(was MFL)·Chemicals·www.epigral.com ↗·Mcap ₹4,727 Cr·Listed 2021
₹1,060.60▼ ₹10.40  (−0.97%)
52W: ₹807 – ₹1,771 · Vol: 33.2K shares · Close 25 Sept
Set Alert

Your Screens

the ones you keep on the screener

Ready-made Screens It Passes

each filter against EPIGRAL's own figure
EPIGRAL passes none of the ready-made screens today.

One or two filters away

which filter, and by how much
92 companies pass it today · see them →
✓
made a profit over the last four quarters₹271 Cr
✗
dividend yield at least 3%0.5%
249 companies pass it today · see them →
✓
made a profit over the last four quarters₹271 Cr
✗
P/E at most 1517.4
✓
market cap at least ₹1,000 Cr₹4,727 Cr
262 companies pass it today · see them →
✓
made a profit over the last four quarters₹271 Cr
✗
P/B at most 12.1
59 companies pass it today · see them →
✗
top 100 by market cap#872
✓
made a profit over the last four quarters₹271 Cr
✗
ROE at least 15%12.2%

6 other ready-made screens it misses on every filter or on more than two. All screens →

EPIGRAL Figuresrebuilt 26 Sept
Market cap₹4,727 Cr
Rank by market cap#872
P/E17.4
P/B2.1
ROE12.2%
Debt to equity0.25
Revenue growth4.8%
Profit growth-37.3%
Net margin10.3%
Dividend yield0.5%
Place in its 52-week range26% of the way up
Below its 52-week high39.8%
Daily turnover₹7 Cr

The last four quarters of filings, consolidated where the company files it, and our end-of-day closes. These are the numbers every filter on this page is held against.

Write Your Own
A screen is a line of English: “debt free with roe above 20%”. Keep one, and it is run again every night; this page then shows whether EPIGRAL passes it.
Open the screener →